HROW - Harrow says dry eye drug Vevye now available in US
2024-01-11 10:34:40 ET
More on Harrow Health
- Despite Q3 Earnings Miss, Harrow Is Still Appealing For 2024
- Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript
- Implications Of Harrow's Short-Term Guidance
- Harrow stock tumbles 38% in wake of Q3 report, revised guidance
- Biggest stock movers today: Home Depot, Fisker, Snap, Beauty Health Company and more
For further details see:
Harrow says dry eye drug Vevye now available in US